Orna Therapeutics
Orna Therapeutics is a pioneering biotechnology company focused on developing next-generation RNA therapeutics using circular RNA technology. The role involves working on RNA production, process optimization, and analytical development to support innovative therapies for complex diseases.
Headquarters
Watertown, Massachusetts, United States
Company Size
51-200 employees
Founded
2019
Orna Therapeutics is a biotechnology company creating fully engineered circular RNA (oRNA) therapeutics — an entirely new class of RNA medicines. The company designs and optimizes circular RNA molecules to enable durable, high‑level protein expression for applications such as vaccines, protein replacement, and cell therapies. Orna operates a platform-driven, engineering-first approach aimed at improving RNA stability, manufacturability, and translational potential to advance next‑generation medicines.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Orna Therapeutics.
12% above the average for this role
Advisor, Analytical Sciences
Eli Lilly and Company
Senior Research Associate
Moderna
Principal Laboratory Science Professional
University of Colorado
Post Doctoral Scholar
The Ohio State University
mRNA Process Development Scientist
Eurofins
Research Engineering/ Scientist Associate I
The University of Texas at Austin